2[(2-chloro-3-methylphenyl)amino]phenylacetic Acid | 127792-27-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2[(2-chloro-3-methylphenyl)amino]phenylacetic Acid
• 英文别名: 2-[(2-Chloro-3-methylphenyl)amino]phenylacetic acid；2-[2-(2-chloro-3-methylanilino)phenyl]acetic acid
• CAS: 127792-27-2
• 化学式: C₁₅H₁₄ClNO₂
• 分子量: 275.735
• InChiKey: QEIKFBABWZXHAB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.13
• 拓扑面积：
  49.3
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-碘苯基乙酸钾 生成 2[(2-chloro-3-methylphenyl)amino]phenylacetic Acid
  参考文献：
  名称：

  MOSER, PETER;SALLMANN, ALFRED;WIESENBERG, IRMGARD, J. MED. CHEM. , 33,(1990) N, C. 2358-2368

  摘要：

  DOI：

文献信息

• Process for phenylacetic acid derivatives
  申请人：Novartis AG

  公开号：EP2275403A1

  公开（公告）日：2011-01-19

  A process for the production of a compound of formula (I), or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable prodrug ester thereof, comprising cleaving a lactam of formula (II) wherein the symbols are as defined, with a base; and precursors therefor and processes for the preparation of the precursors. The compounds of formula (I) are pharmaceutically active compounds which are selective inhibitors of Cyclooxygenase (II).

  一种制备式(I)化合物或其药学上可接受的盐或药学上可接受的前体酯的方法，包括用碱水解式(II)中的内酰胺，其中符号如定义的那样；以及该前体和制备该前体的方法。式(I)化合物是具有药理活性的化合物，其是环氧合酶(II)的选择性抑制剂。
• Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies
  申请人：——

  公开号：US20010034359A1

  公开（公告）日：2001-10-25

  The present invention is directed to compositions that inhibit the nonenzymatic glycation of albumin, as well as methods of using compounds that inhibit albumin glycation for the treatment of glycation-related pathologies.

  本发明涉及抑制白蛋白非酶促糖基化的组合物，并使用抑制白蛋白糖基化的化合物治疗糖基化相关病理的方法。
• Synthesis and quantitative structure-activity relationships of diclofenac analogs
  作者：Peter Moser、Alfred Sallmann、Irmgard Wiesenberg

  DOI：10.1021/jm00171a008

  日期：1990.9

  The synthesis of a series of 2-anilinophenylacetic acids, close analogues of diclofenac, is described. These compounds were tested in two models used for evaluating the activity of nonsteroidal antiinflammatory drugs (NSAID's), inhibition of cyclooxygenase enzyme activity in vitro, and adjuvant-induced arthritis (AdA) in rats. Statistically significant correlations were found between the inhibitory activities of the compounds in these two models, indicating that cyclooxygenase inhibition seems to be the underlying mechanism for the antiinflammatory activity of these compounds. Quantitative structure-activity relationship (QSAR) analysis revealed that the crucial parameters for activity in both models were the lipophilicity and the angle of twist between the two phenyl rings. Optimal activities were associated with halogen or alkyl substituents in both ortho positions of the anilino ring. Compounds with OH groups in addition to two ortho substituents or compounds with only one or no ortho substituents were less active.
• ALBUMIN-BINDING COMPOUNDS THAT PREVENT NONENZYMATIC GLYCATION AND THAT MAY BE USED FOR TREATMENT OF GLYCATION-RELATED PATHOLOGIES
  申请人：EXOCELL, INC.

  公开号：EP1242069A2

  公开（公告）日：2002-09-25
• US6355680B1
  申请人：——

  公开号：US6355680B1

  公开（公告）日：2002-03-12